Clinical review
Vasopressors for the CCRN: Receptors and First-Line Choices
Vasopressors for the CCRN come down to three things: which receptor each drug works on, which drug comes first for each type of shock, and what the nurse watches for once it is running. For septic shock the exam answer is norepinephrine first, vasopressin added when norepinephrine climbs, then epinephrine, with a starting MAP target of 65 mm Hg.
This post covers the receptors, first-line choices by shock type, the safety points that turn up in nursing questions, and two sample questions with walk-throughs. It is a study guide, not a protocol: follow your own unit's orders and policies.
Where vasopressors show up on the CCRN
Shock, sepsis and acid-base problems sit in the Multisystem area (16% of the Adult CCRN), and cardiogenic shock and post-procedure hypotension sit in Cardiovascular (13%). Pressor questions also appear in other systems, for example after a spinal cord injury or a GI bleed. Together that makes vasoactive drugs one of the most reused topics on the exam.
Vasopressor receptors in one table
Alpha-1 receptors in vessel walls constrict and raise SVR. Beta-1 receptors in the heart raise heart rate and contractility. Beta-2 receptors relax vessels and airways. Drugs that do not use adrenergic receptors still work when those receptors are blunted.
| Drug | Main receptors | What it does to the numbers |
|---|---|---|
| Norepinephrine | Alpha-1 more than beta-1 | Raises MAP and SVR with little change in heart rate |
| Epinephrine | Beta-1, beta-2 and alpha-1 | Raises heart rate, contractility and MAP; raises lactate |
| Vasopressin | V1 (vessels), V2 (kidney) | Raises SVR without adrenergic receptors |
| Phenylephrine | Alpha-1 only | Raises SVR; cannot raise cardiac output; reflex slowing |
| Dopamine | Dopamine-1 at low dose, then beta-1, then alpha-1 as dose rises | Varies with dose; more arrhythmias |
| Dobutamine | Beta-1 more than beta-2 | Raises contractility; can lower SVR and BP |
| Angiotensin II | Angiotensin type 1 | Raises SVR; not a catecholamine |
First-line choices by shock type
| Shock type | First choice | What comes next or what to avoid |
|---|---|---|
| Septic | Fluids plus norepinephrine; MAP 65 | Add vasopressin rather than escalate norepinephrine; then epinephrine |
| Septic with cardiac dysfunction | Norepinephrine | Add dobutamine or use epinephrine alone if hypoperfusion persists |
| Cardiogenic | Norepinephrine to support pressure | Add an inotrope for low output; dopamine linked to more arrhythmias |
| Anaphylactic | Intramuscular epinephrine | Epinephrine infusion if refractory |
| Neurogenic | Fluids, then a vasopressor | Atropine for significant bradycardia |
| Hypovolemic or hemorrhagic | Volume or blood | Pressors before volume cause ischemia |
Septic shock: the order the exam expects
The 2021 Surviving Sepsis Campaign guidelines strongly recommend norepinephrine over dopamine, vasopressin, epinephrine and angiotensin II as the first agent, with an initial MAP target of 65 mm Hg. If MAP stays low on norepinephrine, they suggest adding vasopressin instead of pushing norepinephrine higher; the 2021 panel usually started it at norepinephrine 0.25 to 0.5 mcg/kg/min. If MAP is still inadequate on both, they suggest adding epinephrine. The 2026 update keeps the same order, drops the fixed norepinephrine threshold for adding vasopressin and suggests an initial MAP of 60 to 65 mm Hg for patients 65 and older; the Vasopressors and Inotropes Cheat Sheet follows it.
Cardiogenic shock: pressure and output
Norepinephrine is widely used first because it supports pressure while adding some contractility without much tachycardia. In the SOAP II trial dopamine caused more arrhythmias, and in the cardiogenic subgroup more patients died. Phenylephrine raises pressure but not output, so it is not a first-line agent when the heart is failing.
Safety points that turn up in nursing questions
- Correct hypovolemia before or while starting a pressor. The norepinephrine label warns that vasoconstriction in a dry patient can cause organ ischemia and lactic acidosis even when the pressure looks normal.
- Peripheral start is acceptable. SSC 2021 suggests starting peripherally rather than delaying for a central line, for a short time and in a vein at or above the antecubital fossa.
- Extravasation: stop the infusion and infiltrate the area with phentolamine 5 to 10 mg in 10 to 15 mL of saline, per the norepinephrine label.
- Vasopressin: watch for digital, skin and gut ischemia, hyponatremia, bradycardia and falling cardiac output.
- Angiotensin II: thrombosis was more common than with placebo in its main trial, so the label calls for VTE prophylaxis.
- An arterial line is suggested as soon as practical, because cuff pressures are less accurate in shock.
What the CCRN asks about vasopressors
- Which drug to add next when MAP stays low, and why.
- Which drug matches a hemodynamic profile: low SVR, low cardiac index, or both.
- Which finding is an adverse effect to report, such as mottled fingers on vasopressin.
- What to do first when the IV site blanches or swells.
- When the problem is not the pressor at all: an empty tank, a bleeding patient or a failing heart.
Read the numbers in the stem before the options. Shock Types at a Glance pairs each shock with its hemodynamic profile, and the Sepsis and Septic Shock Bundle sets out the timing.
Sample questions: vasopressin and the failing heart in sepsis
A patient in septic shock remains hypotensive (MAP 58 mm Hg) despite adequate fluids and norepinephrine 0.3 mcg/kg/min. The provider adds vasopressin 0.03 units/min. Which rationale BEST explains this choice?
- Vasopressin dilates renal arteries to protect the kidneys
- Vasopressin repairs pulmonary capillary leak
- Sepsis depletes vasopressin; V1 stimulation raises SVR
- Vasopressin is a potent inotrope that raises cardiac output
Show the answer and rationale
Answer: C
- A. Although effects on renal perfusion vary, vasopressin is not added as a renal vasodilator.
- B. Vasopressin does not reverse capillary leak.
- C. Correct. Vasopressin replaces a relative deficiency and raises vascular tone without using adrenergic receptors.
- D. Vasopressin has no direct inotropic action and may slightly lower cardiac output.
Septic shock causes relative vasopressin deficiency as stores are depleted. Adding low-dose vasopressin (about 0.03 units/min) acts on V1 receptors to vasoconstrict independently of adrenergic receptors (which may be downregulated), allowing lower catecholamine doses. The Surviving Sepsis Campaign (2026) suggests adding it when norepinephrine doses are escalating; it sets no fixed threshold, and panelists start it at a median norepinephrine dose of about 0.3 mcg/kg/min (SSC 2021 cited 0.25–0.5). The nurse monitors for digital and mesenteric ischemia and hyponatremia.
Sources: AACN Essentials of Critical Care, 5th ed.; Surviving Sepsis Campaign 2026
A patient in septic shock has a MAP of 72 mm Hg on norepinephrine, adequate preload by passive leg raise testing, and SvO₂ 54%. Echo shows a new LVEF of 25%, and lactate is rising with falling urine output. Which intervention is MOST appropriate?
- Start CRRT for the oliguria
- Increase norepinephrine to reach a MAP of 85
- Give IV furosemide to improve urine output
- Add dobutamine (or switch to epinephrine)
Show the answer and rationale
Answer: D
- A. Oliguria here reflects hypoperfusion, and RRT does not address the cause.
- B. Raising afterload on a depressed LV may further reduce cardiac output.
- C. Diuresis does not fix hypoperfusion and could lower preload.
- D. Correct. Septic cardiomyopathy with persistent hypoperfusion despite adequate MAP and volume warrants inotropic support.
Sepsis-induced cardiomyopathy (reversible biventricular dysfunction) occurs in a substantial share of patients with septic shock. When hypoperfusion persists (rising lactate, low SvO₂, oliguria) despite adequate MAP and volume, the Surviving Sepsis Campaign suggests adding dobutamine to norepinephrine or switching to epinephrine alone. Echocardiography guides the choice, and the nurse monitors for tachyarrhythmias and hypotension from dobutamine’s vasodilating effects.
Sources: Surviving Sepsis Campaign 2026; AACN Core Curriculum, 8th ed.
Walk-through for the vasopressin question: the patient is already on a fair dose of norepinephrine and is still hypotensive. Vasopressin works on V1 receptors, outside the adrenergic system that sepsis blunts, and many septic patients have a relative vasopressin deficiency. It is not an inotrope, it does not repair capillary leak, and its renal effect is water retention through V2, not protective vasodilation. The correct option names the deficiency and the V1 effect.
Walk-through for the low-output question: MAP is already above 65, preload is adequate, yet lactate rises, urine falls and the venous saturation is low. The echo explains it: the heart is not pumping. More norepinephrine chases a pressure that is already fine, a diuretic treats the urine number, and CRRT treats the kidney, not the cause. SSC 2021 suggests adding dobutamine or switching to epinephrine alone for this picture.
Frequently asked questions
What is the first-line vasopressor for septic shock?
Norepinephrine. The Surviving Sepsis Campaign recommends it over dopamine, vasopressin, epinephrine and angiotensin II as the first agent.
When is vasopressin added?
When MAP stays low on norepinephrine, SSC suggests adding vasopressin rather than raising the norepinephrine dose further. The 2021 guideline noted it was usually started at norepinephrine 0.25 to 0.5 mcg/kg/min.
Is dobutamine a vasopressor?
No. Dobutamine is an inotrope that acts mainly on beta-1 receptors and can lower blood pressure. It treats low cardiac output once MAP is supported.
Can norepinephrine run through a peripheral IV?
SSC 2021 suggests starting it peripherally rather than delaying for a central line, for a short time and in a vein at or above the antecubital fossa, with close site checks.
Download on theApp StoreGet it onGoogle Play
Related cheat sheets
- Vasopressors and InotropesReceptors, doses, SSC 2026 septic shock order, push-dose pressors and extravasation
- Shock Types at a GlanceHemodynamic patterns, exam findings and first treatments for each shock type
- Sepsis and Septic Shock BundleSepsis-3 definitions, the Hour-1 bundle and SSC 2026 changes for exam review
- Hemodynamic NormalsNormal adult values, key formulas and how to read the waveforms behind them
Sources
- Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181-1247. Link
- Society of Critical Care Medicine. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026 (summary of recommendations). Link
- Levophed (norepinephrine bitartrate) injection prescribing information. DailyMed. Link
- Vasostrict (vasopressin injection) prescribing information. DailyMed. Link
- Giapreza (angiotensin II) injection prescribing information. DailyMed. Link
- Bloom JE, Chan W, Kaye DM, Stub D. State of shock: contemporary vasopressor and inotrope use in cardiogenic shock. J Am Heart Assoc. 2023;12(15):e029787. Link
- Cardona V, Ansotegui IJ, Ebisawa M, et al. World Allergy Organization anaphylaxis guidance 2020. World Allergy Organ J. 2020;13(10):100472. Link
- Parra MW, Ordoñez CA, Mejia D, et al. Damage control approach to refractory neurogenic shock: a new proposal to a well-established algorithm. Colomb Med (Cali). 2021;52(2):e4164800. Link